Europe

Evolution Scientific joins SAFE-BioPharma

Friday, February 28, 2014 12:05 PM

Evolution Scientific (ESi), a technical service provider to the pharmaceutical, biotech, medical device and other regulated industries, has joined SAFE-BioPharma Association, the nonprofit industry coalition responsible for the ongoing development and implementation of the SAFE-BioPharma digital identity and signature standard.

More... »

WIRB Copernicus Group

AstraZeneca scientists to work alongside researchers at Cancer Research UK Cambridge

Monday, February 24, 2014 11:38 AM

AstraZeneca has entered into a collaboration with the Cancer Research U.K. (CRUK) Cambridge Institute to temporarily locate up to 60 AstraZeneca scientists in the Institute.

More... »


European Healthcare calls for balanced, transparent funding of pharmacovigilance system

Monday, February 24, 2014 10:06 AM

The European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Generic medicines Association (EGA), the European biotech industry (EuropaBio), the Association of the European Self-Medication Industry (AESGP) and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) support the implementation of an effective pharmacovigilance system to ensure patient safety and recognize recent efforts which have been made to ensure greater fairness, proportionality and transparency in some aspects of the proposals for the mechanism of fees to be paid to the EMA for these pharmacovigilance activities. Notably the industry welcomes the improvements regarding the annual fee to be paid by the Marketing Authorization Holders to the EMA. 

More... »

ERT named preferred provider for key quality of life assessments

Friday, February 21, 2014 02:33 PM

ERT, a global solution provider for high-quality patient safety and efficacy endpoint data collection, has been named a preferred provider for the administration of the EuroQol Group’s EQ-5D patient reported outcome (PRO) assessment. Specifically, VIAPhone, ERT’s Interactive Voice Response (IVR) system, has been approved to capture both the EQ-5D-3L and the EQ-5D-5L versions of the quality of life assessment. 

More... »

NHS England responds to concerns about information sharing

Wednesday, February 19, 2014 01:11 PM

Tim Kelsey, national director for patients and information for NHS England, has issued a statement in response to concerns about information sharing, saying, In recent weeks, we have heard from patients, many GPs, their professional organizations and groups like Healthwatch. They have told us very clearly that patients need more time to learn about information sharing, the benefits and their right to object.”

More... »

Sir Stuart Rose to advise on NHS leadership

Friday, February 14, 2014 01:49 PM

Sir Stuart Rose, a highly-regarded business leader in Britain who turned around the fortunes of Marks and Spencer, will advise how the NHS can attract and retain the very best leaders to help transform the culture in under-performing hospitals.

More... »

BioClinica sees eClinical growth in Europe

Friday, February 14, 2014 01:45 PM

BioClinica, a global provider of clinical trial management solutions, has announced that Europe was the fastest growing geographic region in 2013 for its eClinical technology products. The company plans continued investments in its European workforce in of operations and sales, potentially doubling its European eClinical presence in 2014.

More... »

Medical Research Council awards $52.9 million to improve data research

Wednesday, February 12, 2014 01:34 PM

The Medical Research Council (MRC) has made an investment of $52.9 million to improve capability, capacity and capital infrastructure in medical bioinformatics.

More... »

GSK, Uppsala launch $140.6M European program targeting novel antibiotics

Wednesday, February 12, 2014 01:20 PM

Over 30 European universities, research institutes and companies, led by GlaxoSmithKline and Uppsala University, are joining forces in a six-year program supported by the Innovative Medicines Initiative (IMI) to develop novel antibiotics against Gram-negative pathogens in a project called ENABLE (European Gram-Negative Antibacterial Engine), including open calls for candidates outside the consortium.

More... »

Ulster launches a clinical research network for mental health

Thursday, February 6, 2014 11:47 AM

The University of Ulsterhas launched a dedicated Clinical Research Network for Northern Ireland. The new network means that mental health patients from Northern Ireland can now be involved in major national and international research trials. It also will ensure researchers and health professionals have a better understanding of mental health services.  

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs